Nanoencapsulated Doxorubicin Prevents Mucositis Development in Mice

Doxorubicin (DOX), a chemotherapy drug successfully used in the therapy of various types of cancer, is currently associated with the mucositis development, an inflammation that can cause ulcerative lesions in the mucosa of the gastrointestinal tract, abdominal pain and secondary infections. To incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Cristiane M., Horta, Laila S., Soares, Amanda P., Carvalho, Bárbara A., Ferreira, Enio, Lages, Eduardo B., Ferreira, Lucas A. M., Faraco, André A. G., Santiago, Helton C., Goulart, Gisele A. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329927/
https://www.ncbi.nlm.nih.gov/pubmed/34371713
http://dx.doi.org/10.3390/pharmaceutics13071021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329927/
https://www.ncbi.nlm.nih.gov/pubmed/34371713
http://dx.doi.org/10.3390/pharmaceutics13071021

Ejemplares similares